Exon duplication and divergence in the human preproglucagon gene
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, GIP-driven weight loss is synergistically enhanced by adjunct GLP-1R agonism47-49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“and while GIP-mediated weight loss is fully preserved in Glp1r-deficient mice45,49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“GIP-driven weight loss is also synergistically enhanced by adjunct GLP-1R agonism47-49,117.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“GIPR agonist treatment is equally effective in promoting weight loss in obese mice”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
Citations
Cites
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 14,315
Organization and Expression of Eucaryotic Split Genes Coding for Proteins
Breathnach, R., & Chambon, P. (1981) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.50.070181.002025 · Cited by 4,548
Atlas of protein sequence and structure
Chang, M.-Y., Dayhoff, M. O., Eck, R. V., & Sochard, M. R. (1965) · NASA Technical Reports Server (NASA) · Cited by 4,383
A catalogue of splice junction sequences
Mount, S. M. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.2.459 · Cited by 3,797
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing
Sanger, F., Coulson, A. R., Barrell, B. G., Smith, A. J. H., & Roe, B. A. (1980) · Journal of Molecular Biology · doi:10.1016/0022-2836(80)90196-5 · Cited by 3,407
Wahl, G. M., Stern, M., & Stark, G. R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.3683 · Cited by 3,247
Gilbert, W. (1978) · Nature · doi:10.1038/271501a0 · Cited by 2,300
Atlas of Protein Sequence and Structure, 1966.
Hersh, R. T., Eck, R. V., & Dayhoff, M. O. (1967) · Systematic Zoology · doi:10.2307/2412074 · Cited by 1,779
The structure and evolution of the human β-globin gene family
Efstratiadis, A. (1980) · Cell · doi:10.1016/0092-8674(80)90429-8 · Cited by 1,375
Research works printed but not linked: 2
- Unger, R. H.& Orci, L. (eds) Glucagon, Physiology, Pathophysiology and Morphology of the Pancreatic A-cell (Elsevier, New York, 1981).
- O'Farrell, P. Focus 3 (3), 1–3 (1981).
Cited by
Items 201–300 of 595
Nussdorfer, G. G., Bahçelioğlu, M., Neri, G., & Malendowicz, L. K. (2000) · Peptides · doi:10.1016/s0196-9781(99)00193-x · Cited by 65
Isolation and sequence of a human cytochrome P-450 cDNA clone.
Phillips, I. R., Shephard, E. A., Ashworth, A., & Rabin, B. R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.4.983 · Cited by 59
Glucagon-like peptide-1 (7–36 amide): a potent glucagonostatic and insulinotropic hormone
Matsuyama, T., Komatsu, R., Namba, M., Watanabe, N., Itoh, H., & Tarui, S. (1988) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(88)80063-9 · Cited by 64
Glucagon-related peptides in the human gastrointestinal mucosa
Baldissera, F. G. A., & Holst, J. J. (1984) · Diabetologia · doi:10.1007/bf00252412 · Cited by 57
GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH
Li, Q.-X., Gao, H., Guo, Y.-X., Wang, B.-Y., Hua, R.-X., Gao, L., Shang, H.-W., Lu, X., & Xu, J.-D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721198 · Cited by 56
Fitting Markov Chain Models to Discrete State Series such as DNA Sequences
Avery, P. J., & Henderson, D. A. (1999) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.1111/1467-9876.00139 · Cited by 56
Portela‐Gomes, G. M., & Stridsberg, M. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205001108 · Cited by 55
Gut hormones as pharmaceuticals
Holst, J. J. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00185-3 · Cited by 65
Drucker, D. J. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00136-2 · Cited by 65
Circulating markers for endocrine tumours of the gastroenteropancreatic tract
Ardill, J. E. S. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2008.008039 · Cited by 54
Effect of Glucagon-Like Peptide-1 on Gastric Somatostatin and Gastrin Secretion in the Rat
Eissele, R., Koop, H., & Arnold, R. (1990) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529009095514 · Cited by 55
Martins, A. D., Monteiro, M. P., Silva, B. M., Barros, A., Sousa, M., Carvalho, R. A., Oliveira, P. F., & Alves, M. G. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.10.009 · Cited by 55
Glucagon and Glucagon-Like Peptides 1 and 2
Holst, J. J. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2009_35 · Cited by 56
The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome
Drucker, D. J. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00016 · Cited by 51
Pang, J., Feng, J. N., Ling, W., & Jin, T. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.06.003 · Cited by 52
Fukuda, S., Nakagawa, S., Tatsumi, R., Morofuji, Y., Takeshita, T., Hayashi, K., Tanaka, K., Matsuo, T., & Niwa, M. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0696-1 · Cited by 53
All products of proglucagon are elevated in plasma from uremic patients
Orskov, C. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.2.379 · Cited by 52
Molecular Forms of Glucagon-Like Peptide-1 in Human Pancreas and Glucagonomas
UTTENTHEL, L. O., GHIGLIONE, M., GEORGE, S. K., BISHOP, A. E., POLAK, J. M., & BLOOM, S. R. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-3-472 · Cited by 51
Itoh, Y., Tanaka, S., Takekoshi, S., Itoh, J., & Osamura, R. Y. (1996) · Pathology International · doi:10.1111/j.1440-1827.1996.tb03541.x · Cited by 53
Ceddia, R. P., & Collins, S. (2020) · Clinical Science · doi:10.1042/cs20190579 · Cited by 53
Anomalies in the Endocrine Axes of the Guinea Pig: Relevance to Human Physiology and Disease*
Keightley, M.-C., & Fuller, P. J. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-1-30 · Cited by 59
Markers for Neuroendocrine Differentation
Bishop, A. E., Power, R. F., & Polak, J. M. (1988) · Pathology - Research and Practice · doi:10.1016/s0344-0338(88)80040-2 · Cited by 51
Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney
Kervran, A., Dubrasquet, M., Blache, P., Martínez, J., & BATAILLE, D. (1990) · Regulatory Peptides · doi:10.1016/0167-0115(90)90194-2 · Cited by 53
Andrews, P., Hawke, D. H., Lee, T. D., Legesse, K., Noe, B., & Shively, J. E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83886-3 · Cited by 48
Primary structure of glucagon from an elasmobranchian fish, Torpedo marmorata
Conlon, J. M., & Thim, L. (1985) · General and Comparative Endocrinology · doi:10.1016/0016-6480(85)90073-5 · Cited by 48
EJE PRIZE 2018: A gut feeling about glucagon
Knop, F. K. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0197 · Cited by 47
A role for the gut-to-brain GLP-1-dependent axis in the control of metabolism
Burcelin, R., Sérino, M., & Cabou, C. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.09.003 · Cited by 52
Divergent regulation of human and rat proglucagon gene promoters in vivo
Nian, M., Drucker, D. J., & Irwin, D. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.4.g829 · Cited by 47
Hamid, Q. A., Bishop, A. E., Sikri, K. L., Varndell, I. M., Bloom, S. R., & Polak, J. M. (1986) · Histopathology · doi:10.1111/j.1365-2559.1986.tb02468.x · Cited by 47
Exons of the human pancreatic polypeptide gene define functional domains of the precursor.
Leiter, A. B., Montminy, M., Jamieson, E., & Goodman, R. H. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38830-0 · Cited by 50
Metabolic Messengers: glucagon
MacDonald, P. E., & Rorsman, P. (2023) · Nature Metabolism · doi:10.1038/s42255-022-00725-3 · Cited by 43
Precursors to regulatory peptides: their proteolytic processing
Andrews, P., Brayton, K. A., & Dixon, J. E. (1987) · Cellular and Molecular Life Sciences · doi:10.1007/bf01945356 · Cited by 47
Mosaic evolution of prepropancreatic polypeptide.
Yamamoto, H., Nata, K., & Okamoto, H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84542-8 · Cited by 46
Anorexigenic Effects of GLP-1 and Its Analogues
Gallwitz, B. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-24716-3_8 · Cited by 50
PHILIPPE, J., MOJSOV, S., DRUCKER, D. J., & HABENER, J. F. (1986) · Endocrinology · doi:10.1210/endo-119-6-2833 · Cited by 47
The complete structure of the rat VIP gene
Giladi, E., Shani, Y., & Gozes, I. (1990) · Molecular Brain Research · doi:10.1016/0169-328x(90)90036-d · Cited by 48
Oxyntomodulin (glucagon‐37) and its C‐terminal octapeptide inhibit gastric acid secretion
Jarrousse, C., Audousset-Puech, M.-P., Dubrasquet, M., Niel, H., Martínez, J., & BATAILLE, D. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80879-6 · Cited by 50
The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters
Bremholm, L., Hornum, M., Andersen, U. B., & Holst, J. J. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.11.001 · Cited by 44
YAMAGAMI, T., Ohsawa, K., Nishizawa, M., Inoue, C. N., Gotoh, E., Yanaihara, N., Yamamoto, H., & OKAMOTO, H. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb26975.x · Cited by 44
Conlon, J. M., Hansen, H. F., & Schwartz, T. W. (1985) · Regulatory Peptides · doi:10.1016/0167-0115(85)90203-4 · Cited by 44
GLP-1 as a target for therapeutic intervention
Rajeev, S. P., & Wilding, J. P. H. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.08.005 · Cited by 45
CREB/CRTC2 controls GLP‐1‐dependent regulation of glucose homeostasis
Lee, J., Wen, X., Cho, H., & Koo, S. (2017) · The FASEB Journal · doi:10.1096/fj.201700845r · Cited by 45
Kitchen, P. A., Fitzgerald, A. J., Goodlad, R. A., Barley, N. F., Ghatei, M. A., Legon, S., Bloom, S. R., Price, A. B., Walters, J. R. F., & Forbes, A. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.3.g425 · Cited by 54
How glucagon-like is glucagon-like peptide-1?
Ghiglione, M., UTTENTHAL, L. O., George, S. K., & Bloom, S. R. (1984) · Diabetologia · doi:10.1007/bf00276976 · Cited by 42
Lopez, L. C., Li, W., Frazier, M. L., Luo, C. C., & Saunders, G. F. (1984) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040322 · Cited by 42
Luttikhold, J., de Ruijter, F. M., van Norren, K., Diamant, M., Witkamp, R. F., van Leeuwen, P. A. M., & Vermeulen, M. A. R. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12421 · Cited by 44
Chueire, V. B., & Muscelli, E. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000313 · Cited by 50
Cardoso, J. C. R., Vieira, F. A., Gomes, A. S., & Power, D. M. (2007) · Peptides · doi:10.1016/j.peptides.2007.05.016 · Cited by 41
Proglucagon-derived peptides: nomenclature, biosynthetic relationships and physiological roles
Conlon, J. M. (1988) · Diabetologia · doi:10.1007/bf00264761 · Cited by 42
The Vicious Circle of Hepatic Glucagon Resistance in Non-Alcoholic Fatty Liver Disease
Galsgaard, K. D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124049 · Cited by 43
Liraglutide activates autophagy via GLP-1R to improve functional recovery after spinal cord injury
Chen, J., Wang, Z., Mao, Y., Zheng, Z., Chen, Y., Khor, S., Shi, K., He, Z., Li, J., Gong, F., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20791 · Cited by 38
Ørskov, C., & Nielsen, J. H. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80821-4 · Cited by 41
Liu, Y., Si, M., Lü, W., Zhang, L., Zhou, C., Deng, S., & Wu, H. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.03.014 · Cited by 40
Islam, D., Zhang, N., Wang, P., Li, H., Brubaker, P. L., Gaisano, H. Y., Wang, Q., & Jin, T. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90419.2008 · Cited by 39
Evolution of New Hormone Function: Loss and Gain of a Receptor
Irwin, D. M., & Wong, K. S. (2005) · Journal of Heredity · doi:10.1093/jhered/esi024 · Cited by 39
Singular contributions of fish neuroendocrinology to mammalian regulatory peptide research
Conlon, J. M. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00172-5 · Cited by 39
Yonekura, H., Nata, K., Watanabe, T., Kurashina, Y., Yamamoto, H., & Okamoto, H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69165-3 · Cited by 38
Bloom, S. R. (1987) · Gut · doi:10.1136/gut.28.suppl.31 · Cited by 38
Glucagon-like peptide-1 does not have a role in hepatic carbohydrate metabolism
Ghiglione, M., Blázquez, E., UTTENTHAL, L. O., de Diego, J. G., Álvarez, E., George, S. K., & Bloom, S. R. (1985) · Diabetologia · doi:10.1007/bf00703137 · Cited by 39
7 Humoral regulation of intestinal adaptation
Taylor, R. G., & Fuller, P. J. (1994) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80230-7 · Cited by 41
Structure and expression of the vasoactive intestinal peptide (VIP) gene in a human tumor
Gozes, I., Bodner, M., Shani, Y., & Fridkin, M. (1986) · Peptides · doi:10.1016/0196-9781(86)90156-7 · Cited by 40
O'Harte, F. P. M., Gray, A. M., Abdel‐Wahab, Y. H. A., & Flatt, P. R. (1997) · Peptides · doi:10.1016/s0196-9781(97)00201-5 · Cited by 37
Neuroendocrine potential of the colon and rectum
Lluís, F., & Thompson, J. C. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90262-4 · Cited by 40
Arredouani, A. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108824 · Cited by 36
Dong, M., Gao, F., Pinon, D. I., & Miller, L. J. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0025 · Cited by 37
On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes mellitus.
Vilsbøll, T. (2004) · PubMed · Cited by 44
Implementation of GLP-1 Based Therapy of Type 2 Diabetes Mellitus Using DPP-IV Inhibitors
Holst, J. J. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47920-6_33 · Cited by 39
Gregor, M., Menge, H., Stössel, R., & Riecken, E. O. (1987) · Gut · doi:10.1136/gut.28.suppl.9 · Cited by 36
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists
Hansen, K. B., Knop, F. K., Holst, J. J., & Vilsbøll, T. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02086.x · Cited by 35
Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment
Janardhan, S., & Sastry, G. N. (2014) · Current Drug Targets · doi:10.2174/1389450115666140311102638 · Cited by 39
Maternal GLP-1 receptor activation inhibits fetal growth
Qiao, L., Lu, C., Zang, T., Dzyuba, B., & Shao, J. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2023 · Cited by 38
Diversification of the functions of proglucagon and glucagon receptor genes in fish
Irwin, D. M., & Mojsov, S. (2018) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2018.03.003 · Cited by 34
Burcelin, R., ROLLAND, E., Dolci, W., GERMAIN, S., CARREL, V., & Thorens, B. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08510.x · Cited by 37
Kitchen, P. A., Goodlad, R. A., Fitzgerald, A. J., Mandir, N., Ghatei, M. A., Bloom, S. R., Berlanga‐Acosta, J., Playford, R. J., Forbes, A., & Walters, J. R. F. (2005) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607105029004248 · Cited by 34
Yamato, E., Noma, Y., Tahara, Y., Ikegami, H., Yamamoto, Y., Cha, T., Yoneda, H., Ogihara, T., Ohboshi, C., Hirota, M., et al. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92041-w · Cited by 34
Chyan, Y., & Chuang, L. (2007) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/187221407779814570 · Cited by 37
Gut Hormones as Potential New Targets for Appetite Regulation and the Treatment of Obesity
Field, B. C. T., Wren, A., Cooke, D., & Bloom, S. R. (2008) · Drugs · doi:10.2165/00003495-200868020-00002 · Cited by 38
Colwill, M., Povlsen, S., Pollok, R., Patel, K., Goodhand, J., Ahmad, T., & Honap, S. (2025) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaf167 · Cited by 40
Leptin suppresses development of GLP-1 inputs to the paraventricular nucleus of the hypothalamus
Biddinger, J. E., Lazarenko, R. M., Scott, M. M., & Simerly, R. B. (2020) · eLife · doi:10.7554/elife.59857 · Cited by 34
Glucagon-like peptide-I-(7–37) suppresses hyperglycemia in rats
Hendrick, G. K., Gjinovci, A., Baxter, L. A., Mojsov, S., Wollheim, C. B., Habener, J. F., & Weir, G. C. (1993) · Metabolism · doi:10.1016/0026-0495(93)90163-i · Cited by 32
Khan, D., Ojo, O. O., Woodward, O. R. M., Lewis, J. E., Sridhar, A., Gribble, F. M., Reimann, F. M., Flatt, P. R., & Moffett, R. C. (2022) · Biomolecules · doi:10.3390/biom12121736 · Cited by 36
The discovery of glucagon-like peptide 1
Lund, P. K. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.09.001 · Cited by 35
Patzelt, C., & Weber, B. H. F. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04472.x · Cited by 34
Pharmacotherapy of Diabetes: New Developments
Mogensen, C. E. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6 · Cited by 37
Review of Novel Aspects of the Regulation of Ghrelin Secretion
Al–Massadi, O., Lear, P., Müller, T. D., López, M., Diéguez, C., Tschöp, M. H., & Nogueiras, R. (2014) · Current Drug Metabolism · doi:10.2174/1389200215666140505153723 · Cited by 32
Insulinotropic action of human glicentin in dogs
Ohneda, A., Ohneda, K., Nagsaki, T., & Sasaki, K. (1995) · Metabolism · doi:10.1016/0026-0495(95)90288-0 · Cited by 29
Polymorphisms in the transcribed 3′ untranslated region of eukaryotic genes
Levitt, R. C. (1991) · Genomics · doi:10.1016/0888-7543(91)90168-e · Cited by 33
In vivo studies of glucagon secretion by human islets transplanted in mice
Tellez, K., Hang, Y., Gu, X., Chang, C., Stein, R. W., & Kim, S. K. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0213-x · Cited by 28
Neuroendocrine Peptides of the Gut and Their Role in the Regulation of Food Intake
Schalla, M. A., Taché, Y., & Stengel, A. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200007 · Cited by 30
Oshima, I., Hirota, M., Ohboshi, C., & Shima, K. (1988) · Regulatory Peptides · doi:10.1016/0167-0115(88)90093-6 · Cited by 28
Distribution of glucagon-like peptide I in canine and feline pancreas and gastrointestinal tract.
Vaillant, C., & Lund, P. K. (1986) · Journal of Histochemistry & Cytochemistry · doi:10.1177/34.9.3755450 · Cited by 28
Shorrock, K., Roberts, P. A., Pringle, J. H., & Lauder, I. J. (1991) · The Journal of Pathology · doi:10.1002/path.1711650204 · Cited by 28
Intestinal Incretins and the Regulation of Bone Physiology
Ramsey, W. A., & Isales, C. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-66653-2_2 · Cited by 29
A Glimpse of Inflammation and Anti-Inflammation Therapy in Diabetic Kidney Disease
Liu, C., Yang, M., Li, L., Luo, S., Yang, J., Li, C., Liu, J., & Sun, L. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.909569 · Cited by 34
Solid‐phase peptide synthesis of human(Nle‐27)‐oxyntomodulin
Audousset-Puech, M.-P., Dufour, M.-N., Kervran, A., Jarrousse, C., CASTRO, B., BATAILLE, D., & Martínez, J. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80535-x · Cited by 27
Bendet, N., Scapa, E. F., Cohen, O., Bloch, O., Aharoni, D., Ramot, Y., Weiss, M., Halevi, A., & Rapoport, M. J. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410004839 · Cited by 27
Detecting a Changed Segment in DNA Sequences
Avery, P. J., & Henderson, D. A. (1999) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.1111/1467-9876.00167 · Cited by 26
The Human Glucagon Gene Is Located on Chromosome 2
Tricoli, J. V., Bell, G. I., & Shows, T. B. (1984) · Diabetes · doi:10.2337/diab.33.2.200 · Cited by 26
Self-citationHistory of glucagon-like peptide-1 receptor agonists
Darwish, R., Abu-Sharia, G., & Butler, A. E. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108045 · Cited by 29
Novel extrapancreatic effects of incretin
Yamada, Y., Tsukiyama, K., Sato, T. K., Shimizu, T., Fujita, H., & Narita, T. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12495 · Cited by 27
Metadata
- Authors
- Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C.
- ORCID
- Laybourn, Paul J.
- Venue
- Nature
- Published
- 1983-07
- Volume
- 304
- Issue
- 5924
- Pages
- 368-371
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003141714
- Cited by
- 593
- References
- 36
- Citations by year
- 2026: 16 · 2025: 21 · 2024: 21 · 2023: 17 · 2022: 12 · 2021: 16 · 2020: 13 · 2019: 17 · 2018: 14 · 2017: 10 · 2016: 16 · 2015: 10 · 2014: 12 · 2013: 8 · 2012: 13
- FWCI
- 36.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- exon duplication, glucagon, glucagon-like peptide-1, glucagon-like peptide-2, signal peptide, gene structure
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Glucagon, Cricetinae, Humans, Insulin, Proinsulin, Protein Precursors, Proglucagon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.